Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (61-70 of 334) with videos related to

Pageof 34
Sort By:
Gynecologic Oncology|August 23, 2012
A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancerJanelle M Fauci, J Michael Straughn, Soldano Ferrone, et al.
Head & Neck|September 18, 2010
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckMark E Sharafinski, Robert L Ferris, Soldano Ferrone, et al.
The Journal of Biological Chemistry|February 13, 2003
A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell lineTianyu Yang, Beth A McNally, Soldano Ferrone, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2008
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cellsIrina L Tourkova, Galina V Shurin, Soldano Ferrone, et al.
Oncoimmunology|February 7, 2014
EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3Fernando Concha-Benavente, Raghvendra M Srivastava, Soldano Ferrone, et al.
Cell Research|July 28, 2005
Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidineWei Hua Yan, Ai Fen Lin, Chien Chung Chang, et al.
Cancer Research|July 5, 2006
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicityCarlotta Petti, Alessandra Molla, Claudia Vegetti, et al.
Cancer Research|August 3, 2005
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2Xinhui Wang, Eric C Ko, Liaomin Peng, et al.
Molecular Oncology|November 25, 2015
Intracellular antigens as targets for antibody based immunotherapy of malignant diseasesYangyang Wang, Xinhui Wang, Cristina R Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effectsWei Luo, Eric Ko, Jeff Chi-feng Hsu, et al.
Pageof 34

Showing results (61-70 of 334) with videos related to

Sort By:
Pageof 34
Gynecologic Oncology|August 23, 2012
A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancerJanelle M Fauci, J Michael Straughn, Soldano Ferrone, et al.
Head & Neck|September 18, 2010
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckMark E Sharafinski, Robert L Ferris, Soldano Ferrone, et al.
The Journal of Biological Chemistry|February 13, 2003
A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell lineTianyu Yang, Beth A McNally, Soldano Ferrone, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2008
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cellsIrina L Tourkova, Galina V Shurin, Soldano Ferrone, et al.
Oncoimmunology|February 7, 2014
EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3Fernando Concha-Benavente, Raghvendra M Srivastava, Soldano Ferrone, et al.
Cell Research|July 28, 2005
Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidineWei Hua Yan, Ai Fen Lin, Chien Chung Chang, et al.
Cancer Research|July 5, 2006
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicityCarlotta Petti, Alessandra Molla, Claudia Vegetti, et al.
Cancer Research|August 3, 2005
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2Xinhui Wang, Eric C Ko, Liaomin Peng, et al.
Molecular Oncology|November 25, 2015
Intracellular antigens as targets for antibody based immunotherapy of malignant diseasesYangyang Wang, Xinhui Wang, Cristina R Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effectsWei Luo, Eric Ko, Jeff Chi-feng Hsu, et al.
Pageof 34